# Spero Therapeutics Inc. (SPRO) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $13M |
| 2024 | $371,000 |
| 2023 | $933,000 |
| 2022 | $3M |
| 2021 | $3M |
| 2020 | $258,000 |
| 2019 | $5M |
| 2018 | $4M |
| 2017 | $2M |
| 2016 | $335,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | — |
| 2025-09-30 | — |
| 2025-06-30 | — |
| 2025-03-31 | $12,000 |
| 2024-09-30 | $65,000 |
| 2024-06-30 | $114,000 |
| 2024-03-31 | $140,000 |
| 2023-09-30 | $218,000 |
| 2023-06-30 | $269,000 |
| 2023-03-31 | $223,000 |
| 2022-09-30 | $1M |
| 2022-06-30 | $896,000 |
| 2022-03-31 | $247,000 |
| 2021-09-30 | $708,000 |
| 2021-06-30 | $2M |
| 2021-03-31 | $7M |
| 2020-09-30 | $38,000 |
| 2020-06-30 | $51,000 |
| 2020-03-31 | $169,000 |
| 2019-09-30 | $172,000 |
| 2019-06-30 | $67,000 |
| 2019-03-31 | $4M |
| 2018-09-30 | $658,000 |
| 2018-06-30 | $463,000 |

Source: [CompaniesByCap](https://companiesbycap.com/company/SPRO/revenue)